XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restructuring and Other Charges
12 Months Ended
Dec. 31, 2023
Restructuring and Related Activities [Abstract]  
Restructuring and Other Charges

16. Restructuring and Other Charges

In June 2023, the Company committed to exiting its health insurance vertical to increase focus on core verticals and implemented a workforce reduction plan (the “Reduction Plan”) to improve operating efficiency. The Reduction Plan included the elimination of 175 employees, or approximately 28%, of the Company’s workforce. During the year ended December 31, 2023, the Company incurred $4.0 million in severance charges in connection with the workforce reduction, consisting of cash expenditures for employee separation costs of $2.7 million that are expected to be paid through August 2024, and non-cash charges for the modification of certain equity awards of $1.3 million. During the year ended December 31, 2023, the Company recorded a credit of $0.2 million to restructuring and other charges in the accompanying consolidated statements of operations and comprehensive loss related to estimated severance payments that were not made.

In August 2023, the Company sold assets related to its health insurance vertical comprised of all of the issued and outstanding membership interests of Eversurance LLC, a former subsidiary of the Company, to MyPlanAdvocate Insurance Solutions Inc. for cash consideration of $13.2 million. There were no employees of Eversurance LLC at the time of the sale. The assets sold consisted of commissions receivable of $30.8 million, which were expected to be collected over the next seven years, net intangible assets of $1.0 million and other net assets of $0.4 million, including the Company’s Evansville, Indiana office lease. The Company incurred $0.4 million of transaction costs in connection with the sale. Accordingly, the Company recognized a loss on sale of assets of $19.4 million during the year ended December 31, 2023, which amount is included in restructuring and other charges in the accompanying consolidated statements of operations and comprehensive loss. The Company also recorded an impairment charge on the right-of-use asset related to its Cambridge, Massachusetts office lease of $0.4 million during the year ended December 31, 2023 in connection with the Company entering into subleases with two third parties for a portion of the office space. The exit of the health insurance vertical and the Reduction Plan are referred to as the Company's recent restructuring, which was completed by September 30, 2023.

The Company’s restructuring and other charges and balance of its restructuring liability, which was included in accrued employee compensation and benefits, consisted of the following (in thousands):

 

 

Year Ended December 31, 2023

 

 

 

Employee

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separation

 

 

Non-cash

 

 

Loss on Sale of

 

 

Asset

 

 

 

 

 

 

Payments

 

 

Compensation

 

 

Health Assets

 

 

Impairments

 

 

Total

 

Accrued Balance at December 31, 2022

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Expense

 

 

2,709

 

 

 

1,288

 

 

 

19,388

 

 

 

384

 

 

 

23,769

 

Payments

 

 

(2,142

)

 

 

 

 

 

 

 

 

 

 

 

(2,142

)

Adjustments

 

 

(201

)

 

 

 

 

 

 

 

 

 

 

 

(201

)

Non-cash

 

 

 

 

 

(1,288

)

 

 

(19,388

)

 

 

(384

)

 

 

(21,060

)

Accrued Balance at December 31, 2023

 

$

366

 

 

$

 

 

$

 

 

$

 

 

$

366